hydralazine hydrochloride
Generic: hydralazine hydrochloride
Labeler: hikma pharmaceuticals usa inc.Drug Facts
Product Profile
Brand Name
hydralazine hydrochloride
Generic Name
hydralazine hydrochloride
Labeler
hikma pharmaceuticals usa inc.
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
hydralazine hydrochloride 20 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
0641-6231
Product ID
0641-6231_e0fe7653-bdb1-42fc-8277-fc07794f85d5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA213667
Listing Expiration
2026-12-31
Marketing Start
2020-12-18
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
06416231
Hyphenated Format
0641-6231
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
hydralazine hydrochloride (source: ndc)
Generic Name
hydralazine hydrochloride (source: ndc)
Application Number
ANDA213667 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/mL
Packaging
- 25 VIAL, SINGLE-DOSE in 1 CARTON (0641-6231-25) / 20 mL in 1 VIAL, SINGLE-DOSE (0641-6231-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "e0fe7653-bdb1-42fc-8277-fc07794f85d5", "openfda": {"unii": ["FD171B778Y"], "rxcui": ["966571"], "spl_set_id": ["3f5f1204-d289-40e9-be84-a29352f64bfb"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (0641-6231-25) / 20 mL in 1 VIAL, SINGLE-DOSE (0641-6231-01)", "package_ndc": "0641-6231-25", "marketing_start_date": "20201218"}], "brand_name": "HydrALAZINE hydrochloride", "product_id": "0641-6231_e0fe7653-bdb1-42fc-8277-fc07794f85d5", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Arteriolar Vasodilation [PE]", "Arteriolar Vasodilator [EPC]"], "product_ndc": "0641-6231", "generic_name": "HydrALAZINE hydrochloride", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "HydrALAZINE hydrochloride", "active_ingredients": [{"name": "HYDRALAZINE HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA213667", "marketing_category": "ANDA", "marketing_start_date": "20201218", "listing_expiration_date": "20261231"}